GFAP and Cognitive impairment: Plasma GFAP levels are elevated in β-amyloid–positive individuals and in those with mild cognitive impairment (MCI), regardless of cognitive status, and correlate with higher β-amyloid PET signal, even after controlling for tau [199,200].